Alan Ashworth
Direktor/Vorstandsmitglied bei CYTOMX THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Alan Ashworth is the founder of Tango Therapeutics Sub, Inc. (2017) and Tango Therapeutics, Inc. (2017).
He currently holds positions as an Independent Director at CytomX Therapeutics, Inc. (since 2021), and as a Member at the Academy of Medical Sciences, the European Molecular Biology Organization, the UCSF Helen Diller Family Comprehensive Cancer Center, and as an Advisor at Phoenix Molecular Designs Ltd., Catalio Capital Management LP, and Ambagon Therapeutics, Inc. Dr. Ashworth's former positions include Chief Executive Officer at The Institute of Cancer Research, Director at the American Association for Cancer Research, and Director at Breakthrough Breast Cancer.
Dr. Ashworth's education includes an undergraduate degree from Imperial College London and a doctorate from University College London.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Alan Ashworth
Unternehmen | Position | Beginn |
---|---|---|
CYTOMX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 29.09.2021 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Corporate Officer/Principal | - |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Berater | - |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Berater | - |
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The private company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | Präsident | - |
Ehemalige bekannte Positionen von Alan Ashworth
Unternehmen | Position | Ende |
---|---|---|
Breakthrough Breast Cancer
Breakthrough Breast Cancer Miscellaneous Commercial ServicesCommercial Services Part of Breast Cancer Campaign, Breakthrough Breast Cancer provides research and development services for breast cancer. The private company is based in London, UK. The British company was founded in 1993. Breakthrough Breast Cancer was acquired by Breast Cancer Campaign on June 16, 2015. | Direktor/Vorstandsmitglied | - |
The Institute of Cancer Research
The Institute of Cancer Research Pharmaceuticals: MajorHealth Technology The Institute of Cancer Research studies the interplay of genes, proteins, and biological processes that drive the development, growth, and spread of cancers. The private company is based in London, UK. The British company focuses on identifying new treatment targets. | Vorstandsvorsitzender | - |
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | - |
Ausbildung von Alan Ashworth
University College London | Doctorate Degree |
Imperial College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TANGO THERAPEUTICS, INC. | Health Technology |
CYTOMX THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Institute of Cancer Research
The Institute of Cancer Research Pharmaceuticals: MajorHealth Technology The Institute of Cancer Research studies the interplay of genes, proteins, and biological processes that drive the development, growth, and spread of cancers. The private company is based in London, UK. The British company focuses on identifying new treatment targets. | Health Technology |
Breakthrough Breast Cancer
Breakthrough Breast Cancer Miscellaneous Commercial ServicesCommercial Services Part of Breast Cancer Campaign, Breakthrough Breast Cancer provides research and development services for breast cancer. The private company is based in London, UK. The British company was founded in 1993. Breakthrough Breast Cancer was acquired by Breast Cancer Campaign on June 16, 2015. | Commercial Services |
European Molecular Biology Organization | |
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Commercial Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Health Technology |
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The private company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | Consumer Services |